Cruz-González ML, López-Correa SM, Carranza-Madrigal J

Language: Spanish
References: 12
Page: 877-884
PDF size: 442.49 Kb.

ABSTRACT

Objetive: To determine the relationship between anxiety, grades and cardiovascular risk in patients of a cardiometabolic clinic.
Material and Method: An observational, analytical, prospective, cross-sectional study done from January to December 2017 in patients of a cardiometabolic clinic. The Clinical Anxiety Scale was applied, the cardiometabolic risk factors were characterized and the CVR calculation was applied with the score of the SEH and the SEC version 2018.
Results: There were included 183 patients, of which 79% presented a degree of anxiety; insulin resistance, hypertriglyceridemia, hypertension and endothelial dysfunction were more frequent in subjects with anxiety. There was no direct relationship between the degree of anxiety and cardiovascular risk, but it was between the score of the escale of anxiety and the sympathetic response to orthostatism. Neither was there a greater probability of cardiometabolic alterations in the presence of anxiety.
Conclusions: No direct relationship was found between anxiety and cardiovascular risk, but there was a greater frequency of cardiometabolic alterations in the anxious subjects.

REFERENCES

1. Medina-Mora ME, Lara C. Prevalencia de trastornos mentales y uso de servicios: Resultados de la encuesta Nacional de Epidemiología Psiquiatría en México. Salud Mental 2003;26:1-16.

2. Bulbena A, Bobes J, Luque A, Dal-Re R, Ballesteros J, Ibarra N y el grupo de validación en Español de escalas psicométricas. Validación de las versiones en español de la Clinical Anxiety Scale y del Physician Questionnaire para la evaluación de los trastornos de ansiedad. Med Clin (Barc) 2003;121(10):367-374.

3. 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J (2018) 00, 1-98. doi: 10.1093/eurheartj/ehy339.

4. Correti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002;39:257-265. DOI: 10.1016/s0735-1097(01)01746-6.

5. Maser JD (Ed.). Anxiety and Anxiety Disorders. Hillsdale, NY: Lawrence Erlbaum Associates; 1985.

6. Walker JI. The anxious patient. J Fam Pract 1981;12:733- 738.

7. Depression and Anxiety as predictors of 2-year cardiac Events in patients with stable coronary Artery Disease Arch Gen Psychiatry 2008; 65(1):62-71. doi: 10.1001/ archgenpsychiatry.2007.4.

8. Brand RJ, Rosenman RH, Sholtz RI, Friedman M. Multivariate prediction of coronary heart disease in the Western Collaborative Group Study Compared to the findings of the Framingham Study. Circulation 1976Feb;53(2):348-55. DOI: 10.1161/01.cir.53.2.348.

9. Frasure-Smith N, Lespérance F. Depression and Anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008;65(1):62-71. doi: 10.1001/archgenpsychiatry.2007.4.

10. Dodt C, Breckling U, Derad I, et al. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997;30:71-76. DOI: 10.1161/01.hyp.30.1.71.

11. Rabasa C, Dickson SL. Impact of stress on metabolism and energy balance. Curr Opin Behav Sci 2016;9:71-77. doi: 10.1016/j.cobeha.2016.01.011.

12. Kivimäki M, Pentti J, Ferrie JE, Batty GD, Nyberg ST, et al. Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study. Lancet Diabetes Endocrinol 2018;6:705-13. Doi: 10.1016/ S2213-8587(18)30140-2.